FDA bar is high yes but Pfizer is not able to use CBD as this is only possible in Australia, that’s why this investment opportunity is unique.
US listing alone can yield a lot, the big monster we are all fighting now is the overall markets down trend, markets globally is on down trend for the last 10 weeks and who knows when it will end.
- Forums
- ASX - By Stock
- Ann: IHL-675A outperforms existing treatment for arthritis
FDA bar is high yes but Pfizer is not able to use CBD as this is...
-
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)